Is blood of uncomplicated hemochromatosis patients safe and effective for blood transfusion? A systematic review

Journal of Hepatology

Volumn 57, Issue 5, 2012, Pages 1126-1134

  De Buck, Emmy ^a   Pauwels, Nele S ^a   Dieltjens, Tessa ^a   Compernolle, Veerle ^a   Vandekerckhove, Philippe ^a  

^a Centre of Expertise   (Belgium)

Author keywords

Bacterial infections; Blood donation; Evidence based; Hemochromatosis; Viral infections

Indexed keywords

BLOOD TRANSFUSION; ERYTHROCYTE CONCENTRATE; HEMOCHROMATOSIS; HUMAN; IRON METABOLISM DISORDER; IRON OVERLOAD; MICROBIAL CONTAMINATION; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

BELGIUM; BLOOD DONORS; BLOOD TRANSFUSION; HEMOCHROMATOSIS; HUMANS; IRON; RISK FACTORS;

EID: 84867577529     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.040     Document Type: Review

References (56)

1. A. Pietrangelo Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment Gastroenterology 139 2010 393 408 408
2. P.C. Adams, and J.C. Barton Haemochromatosis Lancet 370 2007 1855 1860
3. J. Waalen, V. Felitti, T. Gelbart, N.J. Ho, and E. Beutler Penetrance of hemochromatosis Blood Cells Mol Dis 29 2002 418 432
4. P.C. Adams, and J.C. Barton How I treat hemochromatosis Blood 116 2010 317 325
5. C. Conry-Cantilena Phlebotomy, blood donation, and hereditary hemochromatosis Transfus Med Rev 15 2001 136 143
6. G.L. De Gonzalez Hereditary haemochromatosis and blood donation ISBT Sci Ser 2 2007 12 18
7. O. Nouel, P.M. Voisin, J. Vaucel, M. Dartois-Hoguin, and B.M. Le Yersinia enterocolitica septicemia associated with idiopathic hemochromatosis and deferoxamine therapy. A case Presse Med 20 1991 1494 1496
8. P. Cauchie, W. Vincken, O. Peeters, and K. Charels Hemochromatosis and Yersinia enterocolitica septicemia Dig Dis Sci 32 1987 1438
9. J.R. Boelaert, H.W. van Landuyt, Y.J. Valcke, B. Cantinieaux, W.F. Lornoy, and J.L. Vanherweghem The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients J Infect Dis 156 1987 384 387
10. L. Piroth, P. Meyer, P. Bielefeld, and J.F. Besancenot Yersinia bacteremia and iron overload Rev Med Interne 18 1997 932 938
11. A. Leclercq, L. Martin, M.L. Vergnes, N. Ounnoughene, J.F. Laran, and P. Giraud Fatal Yersinia enterocolitica biotype 4 serovar O:3 sepsis after red blood cell transfusion Transfusion 45 2005 814 818
12. E.M. Walker, and S.M. Walker Review: Effects of iron overload on the immune system Ann Clin Lab Sci 30 2000 354 365
13. F.A. Khan, M.A. Fisher, and R.A. Khakoo Association of hemochromatosis with infectious diseases: expanding spectrum Int J Infect Dis 11 2007 482 487
14. H. Drakesmith, and A. Prentice Viral infection and iron metabolism Nat Rev Microbiol 6 2008 541 552
15. G. Pennings Demanding pure motives for donation: the moral acceptability of blood donations by haemochromatosis patients J Med Ethics 31 2005 69 72
16. B. Butzeck, J. Rialland, P. Brissot, G. Porto, and F. Courtois Management, costs of phlebotomies and use of removed blood in haemochromatosis varies throughout Europe Am J Hematol 86 2011 E81
17. D. Atkins, D. Best, P.A. Briss, M. Eccles, Y. Falck-Ytter, and S. Flottorp Grading quality of evidence and strength of recommendations BMJ 328 2004 1490
18. P.C. Adams, Y. Deugnier, R. Moirand, and P. Brissot The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis Hepatology 25 1997 162 166
19. J.C. Barton, A.J. Grindon, N.H. Barton, and L.F. Bertoli Hemochromatosis probands as blood donors Transfusion 39 1999 578 585
20. J.C. Barton, L.F. Bertoli, and B.E. Rothenberg Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content J Lab Clin Med 135 2000 96 104
21. H. Bell, C. Thordal, N. Raknerud, T. Hansen, V. Bosnes, and R. Halvorsn Prevalence of hemochromatosis among first-time and repeat blood donors in Norway J Hepatol 26 1997 272 279
22. E. Beutler, and T. Gelbart Helicobacter pylori infection and HFE hemochromatosis Blood Cells Mol Dis 37 2006 188 191
23. H.A. Blacklock, M. Dewse, C. Bollard, P. Hudson, D. Barnhill, and S. Jackson Blood donation by healthy individuals with haemochromatosis N Z Med J 113 2000 77 78
24. M. Bove, C. Aurizi, G. Biolcati, F. Sorge, M. Colasanti, and F. Serra Screening for hereditary hemochromatosis in blood donors Vox Sang 101 2011 74 75
25. M. Brandao, J.C. Oliveira, F. Bravo, J. Reis, I. Garrido, and G. Porto The soluble transferrin receptor as a marker of iron homeostasis in normal subjects and in HFE-related hemochromatosis Haematologica 90 2005 31 37
26. F. De Filippi, M. Fraquelli, D. Conte, R. Soffredini, D. Prati, and G. Ronchi High prevalence but low pathogenicity of hepatitis G virus infection in Italian patients with genetic haemochromatosis Ital J Gastroenterol Hepatol 30 1998 529 533
27. M. De Gobbi, S. D'Antico, F. Castagno, D. Testa, R. Merlini, and A. Bondi Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience Haematologica 89 2004 1161 1167
28. A. Del Castillo, S. Gordo, T. Aldamiz, F. De La Calle, and L.A. Varez-Sala Infectious diseases in diagnosed patients of genetic hemochromatosis Am J Hematol 84 2009 E366
29. Y. Deugnier, D. Battistelli, H. Jouanolle, D. Guyader, M. Gueguen, and O. Loreal Hepatitis B virus infection markers in genetic haemochromatosis. A study of 272 patients J Hepatol 13 1991 286 290
30. C.Q. Edwards, L.M. Griffen, C. Drummond, M.H. Skolnick, and J.P. Kushner Screening for hemochromatosis in healthy blood donors. Preliminary results Ann N Y Acad Sci 526 1988 258 273
31. G.P. Feeney, K. Carter, G.S. Masters, H.A. Jackson, I. Cavil, and M. Worwood Changes in erythropoiesis in hereditary hemochromatosis are not mediated by HFE expression in nucleated red cells Haematologica 90 2005 180 187
32. M. Levstik, and P.C. Adams Eligibility and exclusion of hemochromatosis patients as voluntary blood donors Can J Gastroenterol 12 1998 61 63
33. Y.H. Mah, J.H. Kao, C.J. Liu, C.L. Chen, P.J. Chen, and M.Y. Lai Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan Liver Int 25 2005 214 219
34. C.E. McLaren, J.C. Barton, V.R. Gordeuk, L. Wu, P.C. Adams, and D.M. Reboussin Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study Am J Hematol 82 2007 898 905
35. S.M. McDonnell, B.L. Preston, S.A. Jewell, J.C. Barton, C.Q. Edwards, and P.C. Adams A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment Am J Med 106 1999 619 624
36. O. Olakanmi, L.S. Schlesinger, and B.E. Britigan Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages J Leukoc Biol 81 2007 195 204
37. P.L. Lee, N.J. Ho, R. Olson, and E. Beutler The effect of transferrin polymorphisms on iron metabolism Blood Cells Mol Dis 25 1999 374 379
38. T.E. Power, and P.C. Adams Hemochromatosis patients as voluntary blood donors Can J Gastroenterol 18 2004 393 396
39. A.S. Rosvik, R.J. Ulvik, T. Wentzel-Larsen, and T. Hervig Blood donors with hereditary hemochromatosis Transfusion 50 2010 1787 1793
40. H. Sendi, T. Ghaziani, M.R. Zali, P. Adibi, M. Agah, and M. Jazayeri Hemochromatosis mutations in Iranians with hepatitis B virus infection Clin Infect Dis 40 2005 e19 e21
41. Y. Shan, R.W. Lambrecht, and H.L. Bonkovsky Association of hepatitis C virus infection with serum iron status: analysis of data from the third national health and nutrition examination survey Clin Infect Dis 40 2005 834 841
42. I.S.S. Silva, R.M. Perez, P.V. Oliveira, M.I. Cantagalo, E. Dantas, and C. Sisti Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study J Gastroenterol Hepatol 20 2005 243 248
43. M. Wise, L. Finelli, and F. Sorvillo Prognostic factors associated with hepatitis C disease: a case-control study utilizing U.S. multiple-cause-of-death data Public Health Rep 125 2010 414 422
44. M. Luten, B. Roerdinkholder-Stoelwinder, E. Rombout-Sestrienkova, W.J. De Grip, H.J. Bos, and G.J. Bosman Red cell concentrates of hemochromatosis patients comply with the storage guidelines for transfusion purposes Transfusion 48 2008 436 441
45. S.F. Leitman, J.N. Browning, Y.Y. Yau, G. Mason, H.G. Klein, and C. Conry-Cantilena Hemochromatosis subjects as allogeneic blood donors: a prospective study Transfusion 43 2003 1538 1544
46. A.M. Sanchez, G.B. Schreiber, J. Bethel, P.R. McCurdy, S.A. Glynn, and A.E. Williams Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis J Am Med Assoc 286 2001 1475 1481
47. A. Jolivet-Gougeon, O. Loreal, A. Ingels, B. Danic, M. Ropert, and E. Bardou-Jacquet Serum transferrin saturation increase is associated with decrease of antibacterial activity of serum in patients with HFE-related genetic hemochromatosis Am J Gastroenterol 103 2008 2502 2508
48. A. Jolivet-Gougeon, A. Ingels, B. Danic, F. Ussant-Bertel, C. Ferec, and O. Loreal No increased seroprevalence of anti-Yersinia antibodies in patients with type 1 (C282Y/C282Y) hemochromatosis Scand J Gastroenterol 42 2007 1388 1389
49. J.J. Bullen, P.B. Spalding, C.G. Ward, and J.M.C. Gutteridge Hemochromatosis, iron, and septicemia caused by Vibrio vulnificus Arch Intern Med 151 1991 1606 1609
50. F. Courtois, and B. Danic Genetic hemochromatosis and blood donation Ann Med Interne 152 2001 452 454
51. S. Radojska, O. Hengeoz, and B. Gathof Hereditary hemochromatosis patients/carriers as blood donors - a single center experience Transfus Med Hemother 38 2011 32
52. M.L. Buring Haemochromatosis: red cross blood service policy Med J Aust 176 2002 564
53. Guidelines for the Blood Transfusion Services in the United Kingdom. seventh ed. London: TSO (The Stationary Office); 2005.
54. Ministrial Order of the Government of France. Arrêté du 12 janvier 2009 fixants les critères de selection des donneurs de sang 2009.
55. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER). Guidance for industry Variances for Blood Collection from Individuals with Hereditary Hemochromatosis 2001. Available from: http://www.fda.gov/cber/guidelines.htm.
56. D.L. Sackett, M.C. Rosenberg, J.A. Gray, R.B. Haynes, and W.S. Richardson Evidence based medicine: what it is and what it isn't BMJ 312 1996 71 72